T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock

[1]  R. Hong.  The DiGeorge anomaly , 2001, Immunodeficiency reviews.

[2]  Rob J. de Boer,et al.  Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection , 2000, Nature Medicine.

[3]  P. Reiss,et al.  T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy. , 2000, Blood.

[4]  G. Pantaleo,et al.  Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J L Sullivan,et al.  Effect of HIV on thymic function before and after antiretroviral therapy in children. , 2000, The Journal of infectious diseases.

[6]  R Hoh,et al.  Factors influencing T-cell turnover in HIV-1-seropositive patients. , 2000, The Journal of clinical investigation.

[7]  M. Leal,et al.  CD4+ and CD8+ T lymphocyte regeneration after anti‐retroviral therapy in HIV‐1‐infected children and adult patients , 2000, Clinical and experimental immunology.

[8]  Giota Touloumi,et al.  Effect of recent thymic emigrants on progression of HIV-1 disease , 2000, The Lancet.

[9]  M. Clerici,et al.  Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume , 2000, AIDS.

[10]  D. Ho,et al.  Normal T-Cell Turnover in Sooty Mangabeys Harboring Active Simian Immunodeficiency Virus Infection , 2000, Journal of Virology.

[11]  J. Hermans,et al.  Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation , 2000, Bone Marrow Transplantation.

[12]  H. Schuitemaker,et al.  In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Paul Palumbo,et al.  Measuring Recent Thymic Emigrants in Blood of Normal and HIV-1–Infected Individuals before and after Effective Therapy , 1999, The Journal of experimental medicine.

[14]  V. Sasseville,et al.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages , 1999, Nature Medicine.

[15]  J. McCune,et al.  Direct Evidence for Thymic Function in Adult Humans , 1999, The Journal of experimental medicine.

[16]  F Miedema,et al.  Normal telomere lengths in naive and memory CD4+ T cells in HIV type 1 infection: a mathematical interpretation. , 1999, AIDS research and human retroviruses.

[17]  E. Rosenberg,et al.  Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.

[18]  M. Saag,et al.  Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. , 1999, The Journal of clinical investigation.

[19]  Z. Grossman,et al.  T Cell Turnover in SIV Infection , 1999, Science.

[20]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[21]  M. Clerici,et al.  Thymus volume correlates with the progression of vertical HIV infection. , 1999, AIDS.

[22]  Schellekens,et al.  Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts , 1999, Clinical and experimental immunology.

[23]  S. Kostense,et al.  Diversity of the T‐cell receptor BV repertoire in HIV‐1‐infected patients reflects the biphasic CD4+ T‐cell repopulation kinetics during highly active antiretroviral therapy , 1998, AIDS.

[24]  Louis J. Picker,et al.  Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.

[25]  A. Noest,et al.  Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy , 1998, AIDS.

[26]  H. Schuitemaker,et al.  Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. , 1998, The Journal of infectious diseases.

[27]  P. Schnyder,et al.  Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy , 1998, Nature Medicine.

[28]  R. Grant,et al.  High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. , 1998, The Journal of clinical investigation.

[29]  R P Johnson,et al.  Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Alan S. Perelson,et al.  Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen , 1998, The Journal of experimental medicine.

[31]  A S Perelson,et al.  Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.

[32]  Rob J. De Boer,et al.  Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation , 1998, Nature Medicine.

[33]  E. Rosenberg,et al.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.

[34]  J. McCune,et al.  T cell turnover in HIV-1 disease. , 1997, Immunity.

[35]  J. V. van Dongen,et al.  Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion. , 1997, Journal of immunology.

[36]  J. Zack,et al.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection , 1997, Journal of virology.

[37]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[38]  H. Clifford Lane,et al.  HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies , 1997, Nature Medicine.

[39]  Z. Grossman,et al.  T-cell homeostasis in HIV infection is neither failing nor blind: Modified cell counts reflect an adaptive response of the host , 1997, Nature Network Boston.

[40]  Niels Schaft,et al.  T cell telomere length in HIV-1 infection: No evidence for increased CD4+ T cell turnover☆ , 1997 .

[41]  C. Polman,et al.  Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. , 1997, The Journal of clinical investigation.

[42]  H. Lane,et al.  Telomere Length, Telomerase Activity, and Replicative Potential in HIV Infection: Analysis of CD4+ and CD8+T Cells from HIV-discordant Monozygotic Twins , 1997, The Journal of experimental medicine.

[43]  Niels Schaft,et al.  T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4+ T Cell Turnover , 1996, Science.

[44]  M. Ritter,et al.  Thymic involution with ageing: obsolescence or good housekeeping? , 1996, Immunology today.

[45]  D. Schatz,et al.  T-cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells , 1996, Molecular and cellular biology.

[46]  M. Roederer,et al.  CD8 naive T cell counts decrease progressively in HIV-infected adults. , 1995, The Journal of clinical investigation.

[47]  R. Rabin,et al.  Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. , 1995, The Journal of clinical investigation.

[48]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[49]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[50]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[51]  D. Ho,et al.  Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse , 1994, Journal of virology.

[52]  I. Thior,et al.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1. , 1994, Science.

[53]  P. Pileri,et al.  Antigen-independent activation of naive and memory resting T cells by a cytokine combination , 1994, The Journal of experimental medicine.

[54]  D. Vergani,et al.  T cell activation and disease severity in HIV infection , 1993, Clinical and experimental immunology.

[55]  J. Sprent.  Lifespans of naive, memory and effector lymphocytes. , 1993, Current opinion in immunology.

[56]  I. Keet,et al.  Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.

[57]  Anthony S. Fauci,et al.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.

[58]  Steven Wolinsky,et al.  Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  F. Miedema,et al.  Programmed death of T cells in HIV-1 infection. , 1992, Science.

[60]  H. Schuitemaker,et al.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population , 1992, Journal of virology.

[61]  R. Redfield,et al.  Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease , 1992, Journal of virology.

[62]  P. Simmonds,et al.  Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort , 1991, The Lancet.

[63]  R. V. van Lier,et al.  Immunological and virological markers in individuals progressing from seroconversion to AIDS. , 1991, AIDS.

[64]  D. Ho,et al.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.

[65]  P. Simmonds,et al.  HLA HAPLOTYPE A1 B8 DR3 AS A RISK FACTOR FOR HIV-RELATED DISEASE , 1988, The Lancet.

[66]  M. Lederman,et al.  Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. , 2000, The Journal of infectious diseases.

[67]  B. Haynes,et al.  The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. , 2000, Annual review of immunology.

[68]  J. Sarthou,et al.  Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution. , 2000, The Journal of infectious diseases.

[69]  F Miedema,et al.  T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). , 2000, Blood.

[70]  F. Miedema,et al.  T cell dynamics in HIV-1 infection. , 1999, Advances in immunology.

[71]  A. Haase,et al.  Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.

[72]  H. Schuitemaker,et al.  Rapid CD4+ T-cell turnover in HIV-1 infection: a paradigm revisited. , 1998, Immunology today.

[73]  C. Polman,et al.  Treatment with depleting CD 4 monoclonal antibody results in a preferential loss of circul ; ating naive T cells but does not affect IFN-gamma secreting TH 1 cells in humans , 1997 .

[74]  R. V. van Lier,et al.  AIDS pathogenesis: a dynamic interaction between HIV and the immune system. , 1990, Immunology today.

[75]  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1990, Disease markers.

[76]  N. Simmons,et al.  Letter: Fish and shellfish hygiene. , 1975, Lancet.